Hydrochloric Acid → 2-Amino-indan-5-sulfonic acid (5-isopropyl-[1,3,4]thiadiazol-2-yl)-amide hydrochloride
Reaktionsgleichung
[CH:1]([C:4]1[S:8][C:7]([NH:9][S:10]([C:13]2[CH:14]=[C:15]3[C:19](=[CH:20][CH:21]=2)[CH2:18][CH:17]([NH:22]C(=O)C)[CH2:16]3)(=[O:12])=[O:11])=[N:6][N:5]=1)([CH3:3])[CH3:2].[ClH:26]>>[ClH:26].[CH:1]([C:4]1[S:8][C:7]([NH:9][S:10]([C:13]2[CH:14]=[C:15]3[C:19](=[CH:20][CH:21]=2)[CH2:18][CH:17]([NH2:22])[CH2:16]3)(=[O:12])=[O:11])=[N:6][N:5]=1)([CH3:3])[CH3:2]Komponenten
3
Versuchsvorschrift
N-[5-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-indan-2-yl]-acetamide (96 mg) was heated and stirred for 27 hours in 10 ml 2N hydrochloric acid at 100° C. After completion a clear solution occurred. This was evaporated to dryness and the solid residue was used without further purification.
Aufarbeitung
- customThis was evaporated to dryness
- customthe solid residue was used without further purification
Quellen und Nachweise
- ORD-Eintrag
- ord-5075e4d3dbed44eabd6eac14669eea2a
- Quelldatensatz
- uspto-grants-2010_08
- Patentnummer
- US07772257B2
Notizen zur Reaktion
Wird geladen…